Objectives: Osteoarthritis (OA) is a leading cause of disability, but the relationship with premature mortality remains uncertain. We aimed to investigate the relationship between OA and mortality from any cause and from cardiovascular disease (CVD).
with OA are at increased risk of premature mortality compared to the general population. [11] [12] [13] However, this evidence is heterogeneous and limited by the lack of adjustment for appropriate confounders.
Given this, the purpose of this study was to: i) analyze data from a prospective cohort study on the risk of CVD mortality in OA compared to a non-osteoarthritis cohort, adjusting for important medical morbidities and other confounders; ii) to systematically review the available literature and perform a meta-analysis to determine whether people with OA present a differential risk of overall and CVD mortality than those without OA. We hypothesized that people with OA had a significant higher risk of overall and CVD death compared to those without OA.
MATERIALS AND METHODS

Prospective cohort study
Overall cohort
Previously unpublished data from the Progetto Veneto Anziani (PRO.V.A. study)
were used to investigate the risk of overall and CVD mortality in people with OA over a mean follow-up of 4.4 years. The Pro.V.A. study is an observational cohort study on the Italian population aged over 65 years. The study population initially included 3,099 older Caucasian adults (1,245 men/1,854 women), who were randomly selected between 1995 and 1997 using a multistage stratified method, in two North Italian towns (Camposampiero and Rovigo). Additional details about the study design has been previously reported.
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Participant selection
After excluding 172 participants without information about OA, data from 2,927 participants (men:1,179/ women:1,748) were gathered. Hand, hip and knee OA presence was assessed through medical history and records, previous x-ray reports, and clinical evaluation. This latter evaluation included for the hand the presence of Heberden nodes, stiffness, pain at passive moment; for the knee: deformity, pain at passive movement, reduced passive mobility and crepitus; for the hip: pain at passive movement, rotation and palpation, and reduced external rotation. The diagnosis of OA was finally confirmed by a rheumatologist using a standardized algorithm. 15 Mortality was ascertained through direct reviewing of single death certificate, and the main cause of death was recorded using the ICD-9. Death for CVD reasons was defined using the ICD-9 codes from 390 to 459.
Statistical analysis
Due to the small number of death attributed to non-CVD, it was not possible to appropriate analyses overall mortality, over CVD mortality from this dataset.
Accordingly, the risk of CVD mortality associated with OA was investigated using 23 (all as continuous). For all the scores, with exception of GDS, the higher the score the better the status. In the multivariate analysis, data were missing for 258 (=8.8%) of the participants, mainly for information about orthostatic hypotension (n=142), glycosilated hemoglobin (n=244), and MMSE (n=125).
Risk estimates were computed for any joint and anatomical region affected (hand, hip or knee). All analyses were performed using the SPSS 21.0 for Windows (SPSS Inc., Chicago, IL). Statistical significance was assumed for a two-tailed p-value <0.05.
Systematic Review
This systematic review was conducted following the MOOSE (Meta-analysis of observational studies in epidemiology) guidelines and data reporting was performed in agreement with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.
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Data sources and literature search strategy
We created search strategies for the concepts of "osteoarthritis" and "mortality" using a combination of standardized terms and keywords harvested from indices, thesauri, and on-topic articles (Supplementary Table 1 We further conducted a manual search of reference lists of included and other relevant articles. Authors were contacted in case of lacking information. All articles were reviewed for inclusion by two independent reviewers (NV and BS). Any discrepancies were resolved by consensus with a third reviewer (EM). 
Study selection
Outcomes
The primary outcome was: -overall mortality in OA compared to non-OA participants. Secondary outcomes included: overall mortality based on anatomical site of OA (i.e. hand, hip and knee) and CVD mortality.
Assessment of study quality
The Newcastle-Ottawa Scale (NOS) 26 was used to evaluate study quality. The NOS assigns a maximum of nine points to studies of highest quality according to three quality parameters: selection (four points), comparability (two points), and outcome (three points). Each included study was assessed by three reviewers. If discrepancies arose in appraisal, these were addressed by a joint re-evaluation of the article (MS, SM and TS).
Data synthesis and statistical analysis
To compensate for potential between-study heterogeneity, we calculated a pooled HR using DerSimonian-Laird random-effect model. 27 Statistical heterogeneity across studies was assessed using the Cochrane I 2 metric and chi-square statistics. 28 Since the diagnostic criteria for OA involve clinical and radiological parameters [29] [30] [31] and evidence has suggested that radiological findings may poorly correlate to clinical presentation 32 , in absence of universally agreed recommendations we initially (primary analyses) pooled HRs of overall mortality as provided by the studies regardless of method of diagnosis.. Joint specific estimates for overall mortality and CVD specific death were computed. Within-study pooled estimates were also calculated as necessary (e.g. only joint-specific HRs provided).
Given significant statistical heterogeneity (I 2 >50%) 33 , we conducted meta-regression analyses investigating the following moderators: continent (Europe vs. others), type of diagnosis of OA (clinical vs. radiological vs. combined); follow-up duration, NOS score, number of adjustments (all by median value); death ascertainment (using death certificates or other tools), and number of sites affected.
Publication bias was assessed by visually inspecting funnel plots and using the BeggMazumdar Kendall tau 34 and the Egger bias test. 35 To account for potential publication bias, we used a 'trim-and-fill' method, based on the assumption that the effect sizes of all the studies are normally distributed around the center of a funnel plot. In the event of asymmetries, this procedure adjusts for the potential effect of unpublished (imputed) studies. 36 All analyses were performed using Comprehensive Meta-Analysis 3.
RESULTS
Prospective cohort study
Baseline characteristics
In the PRO.V.A. study, participants with OA (N=1,858; 63.5%) were significantly older, with a greater proportion of women compared to those without OA (n=1,069) ( Table 1) . Subjects with OA had also a significantly higher presence of potential risk factors for early mortality, including lower GNRI, preserved number of ADLs, and higher presence of depressive symptoms, frailty, osteoporotic fractures, orthostatic hypotension and hypertension, diabetes and CVD, compared to the non-OA group (Table 1) .
Follow-up and CVD mortality
Over the 4. 
Search results
In total, 2,139 non-duplicated articles were identified. After excluding 2,124 articles based on title/abstract review, 15 articles were fully retrieved and six were included [37] [38] [39] [40] [41] [42] along with data from the PRO.V.A study (Supplementary Figure 1) . For one conference abstract 38 , additional data were gathered from the Authors.
Study and Population Characteristics
As reported in Table 3 , the seven meta-analyzed studies followed 28,559 participants (OA: 10,018/non-OA: 18,541) for a median duration of 12 (IQR: 6.5 to 18) years.
Participants were all community-dwellers, mainly European (N=4; 57%). The assessment of OA was heterogeneous across studies with two 37, 38 and five (PRO.V.A) and [39] [40] [41] [42] reporting a radiological and a combined (clinical + radiological) assessment, respectively. Different methods of death ascertainment were also observed, but six out of seven were of high reliability and quality [37] [38] [39] [40] [41] . Finally, among the studies included, four provided data also for CVD mortality (PRO.V.A) and 37, 38, 41 .
Quality Assessment
The median NOS score was seven (IQR: 6-8). The most common source of bias was the ascertainment of exposure (particularly missing data on radiological or standardized criteria for the assessment of OA; Supplementary Table 3) . On the other, only one study has not considered pertinent linkage to high-quality records. 42 For the calculation of pooled overall mortality estimate we used joint-specific HRs for three studies. [40] [41] [42] Compared to those without OA, participants with OA had no significantly different risk for overall mortality (HR=1.10; 95% CI: 0.97 to 1.25; p=0.12; I 2 =67%; Figure 1 ), also after adjusting for a median of 13 (IQR: 9 to 14)
confounders (Supplementary Table 4 ). After excluding studies providing risks for site specific OA, the pooled risk of death from all causes was found to be significant with low heterogeneity (HR=1.18; 95% CI: 1.08 to 1.28; p<0.001; I 2 =47%).
Sub-group analyses demonstrated that the presence of OA in hand, hip and knee was not associated with an increased risk of mortality (Figure 1) . Funnel plot inspection indicated that publication bias was unlikely, as confirmed by Begg's (p=0.90) and
Egger's tests (p=0.89).
Hazard ratios for cause-specific (CVD) mortality
In four studies (PRO.V.A) and 37, 38, 41 , OA was significantly associated with CVD death without heterogeneity or publication bias (HR=1.21; 95% CI: 1.10 to 1.34; p<0.001; I 2 =0%). Cause-specific mortality for single joints could not be computed due to the limited number of studies.
Meta-regression analysis
Since the overall mortality analyses showed evidence of heterogeneity (I 2 =67%), a meta-regression analysis was undertaken ( Table 4) . In a great part of the strata heterogeneity remained high. However, in some studies there was a significantly higher risk of overall mortality and a moderate-to-substantial reduction of between-multiple joints affected; radiological diagnosis of OA.
Since the pooled HR for hand OA on overall mortality appeared to be marginally protective (p=0.07), a sensitivity analysis was conducted to remove the effect of three datasets (PRO.V.A 40, 41 
DISCUSSION
To the best of our knowledge, this is the first meta-analysis investigating the association between OA and mortality. The seven meta-analyzed studies (including 10,018 participants with and 18,541 people without OA) demonstrated that the presence of OA was not associated with mortality, although this appeared to substantially depend on between-study heterogeneity. When analyzing studies conducted in Europe, we observed a significantly higher risk of mortality and lower heterogeneity. A significant confounding factor to mortality seems to be the inclusion of the studies reporting data on hand OA. Finally, when considering cause-specific mortality, it appears that people with OA are at increased risk of CVD mortality.
It is known that participants with OA frequently exhibit a number of medical morbidities which increase their risk for death. 8, 39, 43 In the PRO.V.A. study, people with OA reported a higher presence of frailty, cardiovascular and metabolic diseases than those without. The role of these potential confounders in explaining the relationship between OA and mortality seems to be relevant 44 , consistent with the findings of a recent large scale prospective study 37 reinforcing the importance of CVD risk in influencing mortality of people with OA. In the PRO.V.A. study we have tried to better identify the specific risk factors for mortality in participants with OA, in order to propose appropriate and specific interventions. Independent predictors of early death significantly different between those with OA and those without were diabetes, CVD, frailty and poorer nutrition index. Hierarchically, frailty seems to be the most important and, since frailty is reversible if appropriately treated 45 , our findings suggest that people with OA should be more active to reduce the risk of premature death. Thus, the association between OA and overall mortality appears to be more related to confounders than for OA itself. This is likely supported in our meta-analysis by strata analysis as the number of adjustments appeared to partially explain between-study heterogeneity. Strata analyses suggested not only that ethnicity could be a potential risk modifier, but also that evidence of an association may depend on study methodology. Particularly, our study highlights the need of providing evidence-based or at least consensus-based criteria for homogenous case ascertainment.
The secondary analyses explored whether the anatomical site of OA was associated with earlier mortality. Hip or knee OA did not predict early death, while for hand OA there was a trend towards a significant reduction in mortality. Since lower limbs OA are associated with high rate of disability and other risk factors for mortality 46 , more research is needed to better understand the role of lower limbs OA in predicting mortality. Regarding hand OA, one study 40 suggests that not only radiographic, but also symptomatic hand OA is protective for mortality, although both these conditions are associated with a higher incidence of CVD. 40 A possible reason is that hand OA was associated with a reduced cancer-related mortality. 40 The reasons of this association are not known and further research is obviously needed.
Our data from the meta-analysis suggests that people with OA are at increased risk of premature mortality due to CVD also after accounting for potential confounders.
People with OA are known to have high levels of CVD 8, 47 , an increased inflammatory profile 9 and low levels of physical activity 48 , all of which may predispose people with OA to premature mortality due to CVD. Moreover, they use a higher proportion of analgesic medications with an unfavorable CVD profile. 49 Given that exercise has been reported as being equally effective in managing some types of CVD as pharmacological interventions 50 , interventions targeting physical activity, frailty and inappropriate medication should be a priority among people with OA at higher risk of mortality. An indirect confirmation of this hypothesis was given by a recent study
showing that patients with knee OA who underwent joint replacement had a lower risk of future CVD events, potentially due to an increased post-operative physical activity levels and decreased use of analgesics compared to pre-operatively. 51 Whilst our primary data and meta-analyses are novel, the findings of our work should be interpreted within its limitations. First, there was some evidence of statistical heterogeneity. However, we attempted to address the issue of between study heterogeneity, as advised by the MOOSE guidelines 24 , suggesting some factors could moderate the association between OA and mortality. Second, it was not possible to stratify our meta-analysis results according to gender, although is known that women are at higher risk of OA and its complications. 52 Third, no study included considered nor the duration of OA at inclusion, nor its progression (clinically or radiologically)
neither the incidence of new cases within the follow-up period. It is therefore unclear whether OA disease progression influenced the outcomes. Furthermore, there was no record as what treatments were prescribed and adhered to in the OA cohort, which clearly might influence mortality. Therefore it is unclear whether disease medication (or symptom modification) impacted on mortality. Fourth, there was some discrepancy in the prevalence of OA across the PRO.V.A. study and the metaanalysis. Reasons for this difference may include: ii) the higher mean age of the PRO.V.A. cohort; and ii) the potential higher prevalence of OA in Italy than other countries. 6 Fifth, we did not assess the association of OA with specific cause mortality other than CVD mortality. This was because there remains limited evidence on other cause mortality for people with OA. Consequently such analyses would have been underpowered and potentially meaningless. However, this should be considered in the future once more studies are published in this area. Finally, the analyses pertaining to site-specific OA are preliminary and should be interpreted with cautious. These are based on a limited number of studies for each outcome, and appeared to be contrasting (lower limbs OA seems to increase and hand OA seems to decrease the risk of death). Further analyses should be undertaken to re-explore the potential importance of joint location with mortality as more studies are published in this area
The strengths of this paper are that it is the first meta-analysis to: i) assess for the association between OA and mortality; and ii) has specifically explored for factors to explain for the heterogeneity in individual study results. This therefore provides important knowledge to increase the awareness of CVD in this population. This is important since CVD is potentially preventable through appropriate timely interventions. 10 to impact on the health of people with osteoarthritis. Secondly, since the cohorts included in these analyses were large, the collective pooled analyses provided lower risk of committing a type two statistical error which would have occurred if these studies were interpreted individually. Finally, in the adjusted analyses, a number and wide variety of different confounders were included in the analysis to be able to answer our research question with these potentially factors accounted for.
In conclusion, it appears that people with OA are at increased risk of CVD-specific mortality while the association with overall mortality is less clear. Additional prospective research is required to further explore the relationship between OA and mortality.
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